Global epidemiology of pneumococcal disease - New prospects for vaccine control

Advances in Experimental Medicine and Biology

Volumn 634, Issue , 2009, Pages 19-29

  Antao, Vinicius C ^a   Hausdorff, William P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFECT; DRUG EFFICACY; EPIDEMIC; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INVASIVE PNEUMOCOCCAL DISEASE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; REVIEW; SEPSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84934440925     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-79838-7_2     Document Type: Review

References (37)

1. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA, Maitland K, English M, Marsh K, Scott JA. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005, 352:39-47. (Pubitemid 40075679)
2. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004, 23:829-833. (Pubitemid 40221025)
3. Bluestone C. and Klein J. Otitis Media in Infants and Children. BC Decker, Inc. Hamilton, Ontario, 2007.
4. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, Lowe B, Bauni E, English M, Berkley JA, Scott JA. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet. 2006, 367:482-488. (Pubitemid 43208904)
5. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006, 25:250-254. (Pubitemid 43379067)
6. Caceres Udina MJ, varez Martinez JA, rgente del CJ, Chumilla Valderas MA, Fernandez AE, Garrido RA, Sanchez GF, Garcia-Marcos L. [Incidence, air pollution and risk factors of acute otitis media in the first year of life: a prospective study]. An Pediatr (Barc). 2004, 60:133-138. (Pubitemid 38418573)
7. Calbo E, Diaz A, Canadell E, Fabrega J, Uriz S, Xercavins M, Morera MA, Cuchi E, Rodriguez-Carballeira M, Garau J. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006, 12:867-872. (Pubitemid 44151286)
8. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005, 54:893-897.
9. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J, Spencer DA. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004, 59:522-525. (Pubitemid 38797527)
10. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001, 344:403-409. (Pubitemid 32128672)
11. Feikin DR and Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002, 35:547-555.
12. Hausdorff WP, Brueggemann AB, Hackell JG, Scott JA. Pneumococcal Serotype Epidemiology. In: Siber G et al. Pneumococcal Vaccines: the Impact of Conjugate Vaccine. ASM Press. Washington, DC. 2008, 139-160.
13. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. The Lancet Infectious Diseases. 2005, 5:83-93. (Pubitemid 40174779)
14. Hedlund J, Sorberg M, Henriques NB, Kronvall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis. 2003, 35:452-458. (Pubitemid 37138942)
15. Henriques NB, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, Svenson SB, Zhou J, Spratt BG, Normark S, Kallenius G. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis. 2001, 184:861-869. (Pubitemid 32881090)
16. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007, 196:1346-1354. (Pubitemid 351412007)
17. Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004, 38:830-835.
18. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, Kurki S, Ronnberg P, Seppa A, Soimakallio S, Sten M, Tanska S, Tarkiainen A, Tukiainen H, Pyorala K, Makela PH. Incidence of Community-Acquired Pneumonia in the Population of Four Municipalities in Eastern Finland. Am J Epidemiol. 1993, 137:977-988. (Pubitemid 23191065)
19. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006, 354:1455-1463.
20. Lagos R, Munoz A, San Martin O, Heitmann I, Loyola H, Levine MM. Secular variations in age incidence (Inc) and serotypes (St) causing invasive pneumococcal disease (IPD) in children 0 to 59 monthsofage (MoA) in the Metropolitan Region (MR), Chile. Proceedings of the 5th International Symposium on Pneumococci & Pneumococcal Diseases. 2006, 164.
21. Lagos R, Munoz A, Valenzuela MT, Heitmann I, Levine MM. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J. 2002, 21:1115-1123. (Pubitemid 35463026)
22. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004, 23:1142-1152.
23. Leibovitz E, Satran R, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003, 22:509-515.
24. Leimkugel J, Adams FA, Gagneux S, Pfluger V, Flierl C, Awine E, Naegeli M, Dangy JP, Smith T, Hodgson A, Pluschke G. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis. 2005, 192:192-199. (Pubitemid 40993388)
25. McCaig LF and Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995, 273:214-219.
26. Melegaro A, Edmunds WJ, Pebody R, Miller E, George R. The current burden of pneumococcal disease in England and Wales. J. Infect. 2006, 52:37-48. (Pubitemid 43115506)
27. Obando I, Arroyo LA, Sanchez-Tatay D, Tarrago D, Moreno D, Hausdorff WP, Brueggemann AB. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2007, 13:347-348. (Pubitemid 46603374)
28. Ortqvist A, Hedlund J, Burman LA, Elbel E, Hofer M, Leinonen M, Lindblad I, Sundelof B, Kalin M. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet. 1998, 351:399-403. (Pubitemid 28064163)
29. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec. 2007, 82:93-104.
30. Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006, 367:740-748. (Pubitemid 43326292)
31. Riquelme PM, Rincon VP, Garcia RL, Tusset CJ, Bravo TR, Fernandez PC. [Acute otitis media in a pediatric primary care unit]. An Pediatr (Barc). 2004, 61:408-412.
32. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG, for the Active Bacterial Core Surveillance/Emerging Infections Program Network. Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era. JAMA. 2001, 285:1729-1735. (Pubitemid 32259907)
33. Rosenblut A, Santolaya ME, Gonzalez P, Corbalan V, Avendano LF, Martinez MA, Hormazabal JC. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J. 2001, 20:501-507. (Pubitemid 32428908)
34. Spencer DA, Iqbal SM, Hasan A, Hamilton L. Empyema thoracis is still increasing in UK children. BMJ. 2006, 332:1333. (Pubitemid 44365394)
35. Tregnaghi M, Ceballos A, Ruttimann R, Ussher J, Tregnaghi P, Peeters P, Hausdorff WP. Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina. Pediatr Infect Dis J. 2006, 25:370-372.
36. UNICEF and WHO. Pneumonia: the forgotten killer of children. United Nations Children's Fund. New York, 2006.
37. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003, 348:1737-1746. (Pubitemid 36514704)